Table of Content

Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Type in 2020
1.4 By Application
Table Application of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Application in 2020
1.5 By Region
Figure Global Biologics and Biosimilars Market Share by Region in 2020
Figure Asia Biologics and Biosimilars Market Share by Region in 2020
Part 2 Key Companies
2.1 Omron
2.1.1 Company Profile
Table Omron Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Biologics and Biosimilars Business Operation of Omron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 TE Connectivity
2.3 Schneider Electric
2.4 Rockwell Automation
2.5 ABB
2.6 Panasonic
2.7 Honeywell
2.8 Siemens
2.9 Eaton
2.10 Phoenix Contact
2.11 Finder
2.12 Hager
2.13 Sprecher+Schuh
2.14 Fuji Electric
2.15 Crouzet Control
2.16 Mitsubishi Electric
2.17 GE
2.18 Carlo Gavazzi
2.19 Schrack
2.20 Dold
2.21 Releco
2.22 Tele Haase
2.23 Delixi
2.24 IDEC
2.25 Brodersen
2.26 CHINT Electrics
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2020 (Million USD)
3.2 Global Market by Company
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2020 (Million USD)
3.3 Global Market by Type
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
3.4 Global Market by Application
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
3.5 Global Market by Forecast
Figure Global Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.3.3 India Market Status and Future Forecast
Figure India Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
5.2 Europe Market by Application
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.2 UK Market Status and Future Forecast
Figure UK Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.3 France Market Status and Future Forecast
Figure France Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
5.4 Europe Market by Forecast
Figure Europe Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
6.2 North America Market by Application
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
6.4 North America Market by Forecast
Figure North America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
7.2 South America Market by Application
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
7.4 South America Market by Forecast
Figure South America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion

List of Figure

List of Table
Table Type of Biologics and Biosimilars
Table Application of Biologics and Biosimilars
Table Omron Overview List
Table Biologics and Biosimilars Business Operation of Omron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Life & Medical Business Operation of TE Connectivity (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of Schneider Electric (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of Rockwell Automation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xxx Business Operation of ABB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xx% Business Operation of Panasonic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 7 Business Operation of Honeywell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2 Business Operation of Siemens (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 0 Business Operation of Eaton (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 4 Business Operation of Phoenix Contact (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 1800 Business Operation of Finder (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2160 Business Operation of Hager (Sales Revenue, Cost, Gross Margin)
Table 2810 Business Operation of Sprecher+Schuh (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 82 Business Operation of Fuji Electric (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Crouzet Control (Sales Revenue, Cost, Gross Margin)
Table A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires. Business Operation of Mitsubishi Electric (Sales Revenue, Cost, Gross Margin)
Table Business Operation of GE (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Carlo Gavazzi (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Schrack (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Dold (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Releco (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Tele Haase (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Delixi (Sales Revenue, Cost, Gross Margin)
Table Business Operation of IDEC (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Brodersen (Sales Revenue, Cost, Gross Margin)
Table Business Operation of CHINT Electrics (Sales Revenue, Cost, Gross Margin)
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)